Ross, A. E., Hughes, R. M., Glavaris, S., Ghabili, K., He, P., Anders, N. M., . . . Antonarakis, E. S. (2017). Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy. Oncotarget.
Chicago Style citaatRoss, Ashley E., et al. "Pharmacodynamic and Pharmacokinetic Neoadjuvant Study of Hedgehog Pathway Inhibitor Sonidegib (LDE-225) in Men With High-risk Localized Prostate Cancer Undergoing Prostatectomy." Oncotarget 2017.
MLA citatieRoss, Ashley E., et al. "Pharmacodynamic and Pharmacokinetic Neoadjuvant Study of Hedgehog Pathway Inhibitor Sonidegib (LDE-225) in Men With High-risk Localized Prostate Cancer Undergoing Prostatectomy." Oncotarget 2017.